4.5 Interaction with other medicinal  products and other forms of interaction  
 Icosapent ethyl was studied at the dose level of four 998  mg capsules/day with the following medicinal products which are typical substrates of cytochrome P450 enzymes : omeprazole, rosiglitazone, warfarin and atorvastatin. No interactions were observed. 
 
